Vaccine effects and impact of vaccination programmes in post-licensure studies

被引:99
作者
Hanquet, Germaine [1 ,2 ]
Valenciano, Marta [3 ]
Simondon, Francois [4 ]
Moren, Alain [3 ]
机构
[1] Univ Ghent, B-9000 Ghent, Belgium
[2] Univ Antwerp, Antwerp, Belgium
[3] EpiConcept, Paris, France
[4] SPMSD, Dept Epidemiol, Lyon, France
关键词
Vaccination; Vaccine effectiveness; Impact; Epidemiology; Observational studies; PNEUMOCOCCAL CONJUGATE VACCINE; ROTAVIRUS VACCINATION; INFLUENZA VACCINE; SURVEILLANCE DATA; EFFICACY; IMMUNIZATION; CHILDREN; DESIGNS; HOSPITALIZATIONS; COUNTRIES;
D O I
10.1016/j.vaccine.2013.07.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Once a vaccine is licensed and introduced in the population, post-licensure studies are required to measure vaccine effectiveness and impact of vaccination programmes on the population at large. However, confusion still prevails around these concepts, making it difficult to discern which effects are measured in such studies and how their findings should be interpreted. We review from the public health evaluation perspective the effects of vaccine-related exposures, describe the methods used to measure them and their assumptions. We distinguish effects due to exposure to individual vaccination from those due to exposure to a vaccination programme, as the latter depends on vaccine coverage, other population factors and includes indirect effects as well. Vaccine (direct) effectiveness is estimated by comparing vaccinated and unvaccinated individuals exposed to the same vaccination programme. The impact of a vaccination programme, defined here as the population prevented fraction when exposure is the programme, is measured by comparing populations with and without a vaccination programme, most commonly the same population before and after vaccination. These designs are based on a number of assumptions for valid inference. In particular, they assume that vaccinees and non-vaccinees do not differ in terms of susceptibility and exposure to the disease or in ascertainment of vaccination and disease status. In pre and post-vaccination design, the population is assumed to have similar baseline transmission, case detection and reporting, risk factors and medical practices in both periods. These principles are frequently violated in post-licensure studies. Potential confounding and biases must be minimized in study design and analyses, or taken into account during result interpretation. It is also essential to define which exposure is evaluated (individual vaccination or vaccination programme) and which effect is measured. This may help decision-makers clarify which type of study is needed and how to interpret the results. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5634 / 5642
页数:9
相关论文
共 67 条
[11]  
CDC, 2005, MMWR-MORBID MORTAL W, V54, P893
[12]  
*CDCP, 2008, MAN SURV VACC PREV D
[13]  
Centers for Disease Control and Prevention, 1999, JAMA-J AM MED ASSOC, V281, P1482, DOI [DOI 10.1001/JAMA.281.16.1482-JWR0428-2-1, 10.1001/jama.281.16.1482-JWR0428-2-1]
[14]  
Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P243
[15]   Epidemiologic methods in immunization programs [J].
Chen, RT ;
Orenstein, WA .
EPIDEMIOLOGIC REVIEWS, 1996, 18 (02) :99-117
[16]   Evaluating new vaccines for developing countries - Efficacy or effectiveness? [J].
Clemens, J ;
Brenner, R ;
Rao, M ;
Tafari, N ;
Lowe, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (05) :390-397
[17]   An Assessment of the Screening Method to Evaluate Vaccine Effectiveness: The Case of 7-Valent Pneumococcal Conjugate Vaccine in the United States [J].
Cohen, Adam L. ;
Taylor, Thomas, Jr. ;
Farley, Monica M. ;
Schaffner, William ;
Lesher, Lindsey J. ;
Gershman, Kenneth A. ;
Bennett, Nancy M. ;
Reingold, Arthur ;
Thomas, Ann ;
Baumbach, Joan ;
Harrison, Lee H. ;
Petit, Susan ;
Beall, Bernard ;
Zell, Elizabeth ;
Moore, Matthew .
PLOS ONE, 2012, 7 (08)
[18]   Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media [J].
Cohen, Robert ;
Levy, Corinne ;
de La Rocque, France ;
Gelbert, Nathalie ;
Wollner, Alain ;
Fritzell, Bernard ;
Bonnet, Eric ;
Tetelboum, Robert ;
Varon, Emmanuelle .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (11) :1001-1007
[19]  
Committee for medicinal products for human use, 2012, PER BEN RISK EV REP
[20]   Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period [J].
De Serres, Gaston ;
Pilishvili, Tamara ;
Link-Gelles, Ruth ;
Reingold, Arthur ;
Gershman, Kenneth ;
Petit, Susan ;
Farley, Monica M. ;
Harrison, Lee H. ;
Lynfield, Ruth ;
Bennett, Nancy M. ;
Baumbach, Joan ;
Thomas, Ann ;
Schaffner, William ;
Beall, Bernard ;
Whitney, Cynthia ;
Moore, Matthew .
VACCINE, 2012, 30 (27) :4067-4072